111 related articles for article (PubMed ID: 7532726)
1. Histocultures of human prostate tissues for pharmacologic evaluation.
Wientjes MG; Pretlow TG; Badalament RA; Burgers JK; Au JL
J Urol; 1995 Apr; 153(4):1299-302. PubMed ID: 7532726
[TBL] [Abstract][Full Text] [Related]
2. Hormone regulation of human prostate in organ culture.
Nevalainen MT; Härkönen PL; Valve EM; Ping W; Nurmi M; Martikainen PM
Cancer Res; 1993 Nov; 53(21):5199-207. PubMed ID: 7693334
[TBL] [Abstract][Full Text] [Related]
3. The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line.
Karr JF; Kantor JA; Hand PH; Eggensperger DL; Schlom J
Cancer Res; 1995 Jun; 55(11):2455-62. PubMed ID: 7538903
[TBL] [Abstract][Full Text] [Related]
4. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Igawa T; Lin FF; Rao P; Lin MF
Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
[TBL] [Abstract][Full Text] [Related]
5. Androgen-dependent and -independent human prostate xenograft tumors as models for drug activity evaluation.
Chen CT; Gan Y; Au JL; Wientjes MG
Cancer Res; 1998 Jul; 58(13):2777-83. PubMed ID: 9661891
[TBL] [Abstract][Full Text] [Related]
6. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
[TBL] [Abstract][Full Text] [Related]
7. Long term organ culture of human prostate tissue in a NASA-designed rotating wall bioreactor.
Margolis L; Hatfill S; Chuaqui R; Vocke C; Emmert-Buck M; Linehan WM; Duray PH
J Urol; 1999 Jan; 161(1):290-7. PubMed ID: 10037426
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of nonmalignant and malignant human prostate in organ culture.
Varani J; Dame MK; Wojno K; Schuger L; Johnson KJ
Lab Invest; 1999 Jun; 79(6):723-31. PubMed ID: 10378515
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a stromal cell model of the human benign and malignant prostate from explant culture.
Planz B; Kirley SD; Wang Q; Tabatabaei S; Aretz HT; McDougal WS
J Urol; 1999 Apr; 161(4):1329-36. PubMed ID: 10081903
[TBL] [Abstract][Full Text] [Related]
10. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
Sinha AA; Sackrison JL; DeLeon OF; Wilson MJ; Gleason DF
Anat Rec; 1996 Aug; 245(4):652-61. PubMed ID: 8837723
[TBL] [Abstract][Full Text] [Related]
11. PSA and PAP as immunohistochemical markers in prostate cancer.
Epstein JI
Urol Clin North Am; 1993 Nov; 20(4):757-70. PubMed ID: 7505984
[TBL] [Abstract][Full Text] [Related]
12. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical localization of an immunoconjugate (antibody IgG against prostatic acid phosphatase conjugated to 5-fluoro-2'-deoxyuridine) in human prostate tumors.
Sinha AA; Quast BJ; Wilson MJ; Reddy PK; Fernandes ET; Ewing SL; Gleason DF
Anticancer Res; 1998; 18(3A):1385-92. PubMed ID: 9673345
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of doxorubicin in human prostate tumors.
Chen CT; Au JL; Wientjes MG
Clin Cancer Res; 1998 Feb; 4(2):277-82. PubMed ID: 9516911
[TBL] [Abstract][Full Text] [Related]
15. Both retinoids and androgens are required to maintain or promote functional differentiation in reaggregation cultures of human prostate epithelial cells.
Goossens K; Deboel L; Swinnen JV; Roskams T; Manin M; Rombauts W; Verhoeven G
Prostate; 2002 Sep; 53(1):34-49. PubMed ID: 12210478
[TBL] [Abstract][Full Text] [Related]
16. [In vitro detection of prostate cancer circulating cells by immunocytochemistry, flow cytometry and RT-PCR PSA].
de la Taille A; Muscatelli B; Colombel M; Jouault H; Amsellem S; Mazeman E; Abbou CC; Chopin D
Prog Urol; 1998 Dec; 8(6):1058-64. PubMed ID: 9894270
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma.
Crook JM; Bahadur YA; Robertson SJ; Perry GA; Esche BA
Cancer; 1997 Jan; 79(1):81-9. PubMed ID: 8988730
[TBL] [Abstract][Full Text] [Related]
18. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
19. Intravenous injection of an immunoconjugate (anti-PSA-IgG conjugated to 5-fluoro-2'-deoxyuridine) selectively inhibits cell proliferation and induces cell death in human prostate cancer cell tumors grown in nude mice.
Sinha AA; Quast BJ; Reddy PK; Elson MK; Wilson MJ
Anticancer Res; 1999; 19(2A):893-902. PubMed ID: 10368631
[TBL] [Abstract][Full Text] [Related]
20. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
